摘要
目的:观察依达拉奉联合β-七叶皂甙钠治疗急性脑梗死的临床疗效。方法:74例急性脑梗死患者随机分为两组,治疗组37例,在常规支持疗法基础上采用依达拉奉+β-七叶皂甙钠治疗;对照组37例,除不使用依达拉奉外,其他同治疗组。结果:治疗组有效率为94.6%,明显高于对照组的73.0%,两组比较差异有统计学意义(P<0.05)。在用药过程及疗程后复查血尿常规、肝肾功能检查,未发现明显不良反应。结论:依达拉奉联合β-七叶皂甙钠治疗急性脑梗死有显著疗效,值得临床推广。
Objective: To investigate the effect of edaravone unites β -aescin in treatment of acute cerebral infarction.Method: 74 cases of acute cerebral infarction were randomly divided into 2 groups, the treatment group is 37 cases, support adoption edaravone of therapy foundation in the normal regulations+ β -aescin cure; the matched group is 37 cases, in addition to doing not use edaravone, other is the same treatment group.Result: The treatment group was efficient to 94.6%, which was more obviously higher than a matched group of 73.0%, two groups compared ( P〈0.05 ) .In the process of using a medicine and reexamine a blood in urine normal regulations, the liver function and kidney function checked after the treatment, didn't discover obviously and badly respond.Conclusion: The edaravone unites β -acscin to cure an acute cerebral to obstruct to have obvious treatment effect.
出处
《中国医学创新》
CAS
2013年第3期16-17,共2页
Medical Innovation of China